ArticleDrug and alcohol review2026
Rethinking Alcohol Harm Reduction.
Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence and Correlates of Non-Alcoholic Beverage Consumption Among People Living with HIV: A Potential Alcohol Reduction Strategy.AIDS and behavior · 2026Article
- Informing low-risk drinking guidelines: a secondary, cross-sectional data analysis of alcohol use and health utility.Addiction science & clinical practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcohol harm reduction (AHR) includes a pragmatic set of strategies to reduce the acute harms of alcohol consumption without necessarily reducing use, such as managed alcohol plans and intoxication management facilities. While well established in illicit drug research, harm reduction's application to alcohol remains less explicitly examined, both conceptually and in terms of policy articulation. In contrast to population-level consumption-reduction strategies - many of which are effective at preventing harm - AHR often places greater emphasis on acute and immediate harms and may require consumers to take an active role, a feature that has raised concerns about industry mobilising 'responsible drinking' narratives. AHR also tends to be subsumed within other alcohol policies and has a less consolidated evidence base. However, drawing on international and Australian evidence, this article outlines practical and ethical reasons for a more explicit focus on AHR, including the substantial burden alcohol places on frontline health systems, its disproportionate impacts on socially disadvantaged populations and its frequent involvement in polydrug use and overdose. AHR can also facilitate cross-sectoral collaboration and lateral policymaking, and contribute to the ethical obligation of policymakers to redress the harms of alcohol commercialisation. Beyond formal policy, AHR already occurs in clinical, educational and nightlife settings. Recognising this, future research and policy efforts should focus on clarifying how harm reduction can be more explicitly integrated within alcohol policy frameworks to complement population-level approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.